Refine your results

to


Search

Short-term cost of interferon-free therapies for all HCV patients high yet cost-effective

Show Citation

January 9, 2017

Authors:

Linas BP, Morgan JR, Pho MT, Leff JA, Schackman BR, Horsburgh CR, Assoumou SA, Salomon JA, Weinstein MC, Freedberg KA, Kim AY.

Background:

Interferon-free regimens to treat hepatitis C virus (HCV) genotype 1 are effective but costly. At this time, payers in the U.S. employ strategies to control costs including: 1) limiting treatment to those with advanced disease, and 2) negotiating price discounts in exchange for exclusivity.

Advertisement
Advertisement